AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 133 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,072,000 | -22.8% | 78,804 | +7.6% | 0.07% | -13.8% |
| Q2 2015 | $1,389,000 | -66.8% | 73,221 | -54.3% | 0.08% | -66.9% |
| Q1 2015 | $4,189,000 | +43.3% | 160,050 | +14.6% | 0.24% | +36.7% |
| Q4 2014 | $2,923,000 | +1.1% | 139,599 | +61.2% | 0.18% | -12.4% |
| Q3 2014 | $2,892,000 | +57.9% | 86,626 | +51.8% | 0.20% | +64.2% |
| Q2 2014 | $1,831,000 | +119.5% | 57,069 | +216.0% | 0.12% | +101.6% |
| Q1 2014 | $834,000 | – | 18,058 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 447,001 | $14,344,000 | 100.00% |
| Broadfin Capital, LLC | 1,620,088 | $51,988,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,899,585 | $93,048,000 | 2.40% |
| Tamarack Capital Management, LLC | 400,000 | $11,656,000 | 2.38% |
| March Altus Capital Management LP | 199,037 | $6,387,000 | 2.34% |
| PRICE MICHAEL F | 240,000 | $7,702,000 | 0.94% |
| DELTEC ASSET MANAGEMENT LLC | 106,151 | $3,406,000 | 0.72% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,207,598 | $102,932,000 | 0.61% |
| CLOUGH CAPITAL PARTNERS L P | 508,800 | $16,327,000 | 0.52% |
| Catalyst Capital Advisors LLC | 86,500 | $2,776,000 | 0.45% |